Method for separating human cerebral cortex neural stem cells
Through the method of collecting, preparing suspension from aborted tissues and capturing specific antibodies, human cerebral cortex neural stem cells were successfully isolated and cultivated, solving the problem of treatment of nerve damage diseases and providing efficient tools for clinical application and research , improves cell purity and separation efficiency, and promotes the development of new therapies.
Patent Information
- Application Number
- CN202411093386.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-09
- Publication Date
- 2024-11-22
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing technology has failed to effectively solve the problem of nerve cell death or degeneration caused by nerve damage and neurodegenerative diseases, and lacks effective treatment methods. The isolation method of new human adult neural stem cells has become a new hope for curing these diseases.
Through the collection of aborted tissue, preparation of single-cell suspension of neural tissue, and immune capture and culture of neural stem cells, CD133 and CD29 antibodies are used to achieve specific capture and activation, combined with flow cell surface characteristic antigen analysis for identification, extraction and cultivation of human sources Neural stem cells in the cerebral cortex.
It has successfully improved the isolation efficiency and purity of neural stem cells, provided an important tool for clinical application and research, promoted the research on disease mechanisms and the development of new therapies, and has high educational and training value.
Smart Images

Figure CN118995612A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of stem cell extraction and separation, and in particular relates to a method for separating human cerebral cortex neural stem cells. Background Art
[0002] Neurological injury diseases and neurodegenerative diseases are major medical challenges facing mankind. There are a large number of patients with these diseases, and the disability rate is high. There is currently no effective treatment for the complete death or degeneration of nerve cells. In my country, there are 28.79 million people suffering from stroke (Wang Yongjun et al., 2022); the number of patients with Alzheimer's disease is about 15.07 million; in addition, the total number of patients with cerebral palsy, spinal cord injury, Parkinson's disease and amyotrophic lateral sclerosis exceeds 11 million. Each of the above diseases causes different types and degrees of disability. Among them, limb disability caused by stroke (about 65% of patients have hemiplegia symptoms) is the number one cause of disability in my country, which brings heavy mental and economic burdens to patients, families and society. Patients and the market are eager for a product that effectively treats such diseases.
[0003] Since neurological injury diseases and neurodegenerative diseases are characterized by the complete death or degeneration of nerve cells, there is still no effective drug for such diseases. However, a large number of clinical research results show that "regenerative medicine therapy" that transplants neural stem cells into the brain to replace dead or degenerated nerve cells and reshape neural structures has become a new hope for curing such diseases. New human adult neural stem cell products are on the horizon! The in vitro culture system of primary human adult neural stem cells is an important tool for studying neuroscience and developing related treatment strategies. Currently, research and application at home and abroad are under active development. For this reason, a method for isolating human cortical neural stem cells is proposed. Summary of the invention
[0004] The purpose of the present invention is to provide a method for isolating human cerebral cortex neural stem cells, aiming to solve the problems raised in the above background technology.
[0005] To achieve the above object, the present invention provides the following technical solutions:
[0006] A method for isolating human cerebral cortex neural stem cells, comprising the following steps:
[0007] Step 1: Collection of abortion tissue;
[0008] Step 2, preparation of single cell suspension of neural tissue;
[0009] Step 3, neural stem cell immune capture;
[0010] Step 4: Cultivating neural stem cells;
[0011] Step 5: Identification of neural stem cells.
[0012] Furthermore, the specific operation of step 1 is as follows: for the intact abortion tissue induced by drugs, after washing it with HBSS for several times, the meninges are peeled off with forceps, and the parts of the cerebral cortex in the abortion tissue are separated by microdissection, and different tissues are cut into pieces less than 1 mm 3 The tissue blocks were placed in PBS pre-cooled at 4°C for later use.
[0013] Furthermore, the specific operation of step 2 is: centrifuge the tissue block at a centrifugal force of 150g for 3 minutes, and then discard the supernatant; place the centrifuged tissue block on ice for 15 minutes, and flick the tissue block every 2 minutes until the tissue block is completely resuspended; use a pipette to blow the tissue block up and down every 30 seconds until the tissue block becomes a uniform single-cell suspension, and then centrifuge the obtained single-cell suspension at a centrifugal force of 300g for 10 minutes; then use complete culture medium to resuspend the cell pellet, count the cells, and let it stand for subsequent culture experiments.
[0014] Furthermore, the specific operation of step 3 is: using CD133 antibody and CD29 antibody to achieve specific capture and activation of neural stem cells.
[0015] Furthermore, the specific steps of step 3 are as follows:
[0016] Step 31, preparation of coated plates: coat the plates with 0.01% poly-L-ornithine and 0.01% fibronectin in sequence overnight; wash the plates with DPBS, and then coat the plates with 2ug / ml neural stem cell-specific antibodies CD133 and CD29 antibodies, incubate at 37°C for 1 hour or at 4°C overnight, and then store the plates at 4°C for later use. The prepared plates should be used within 3 days;
[0017] Step 32, adding cell suspension and incubation: Before use, remove the liquid in the plate and add 1×10 7 cells / mL neural tissue single cell suspension was added to the coated dish, mixed thoroughly, and the dish was placed in an incubator for 4 to 8 hours;
[0018] Step 33, washing the non-adherent cells: after the incubation is completed, tilt the plate and pour out all the liquid at the bottom of the plate;
[0019] Step 34, adding complete culture medium: slowly add 1-2 ml of complete culture medium along the wall of the dish, and repeat step 33 once;
[0020] Step 35, add a sufficient amount of neural stem complete culture medium to the plate, and then place the plate in a 37° C., 5% incubator for culture.
[0021] Furthermore, the specific operation of step 4 is as follows: after culturing neural stem cells for 24 hours, the complete culture medium is replaced, and then half the amount of fresh complete culture medium is replaced every 2 days. When the cell confluence reaches 50-60%, digestion and 1:3 subculture operation are performed, and relevant identification is performed after one generation of transfer culture.
[0022] Furthermore, the specific operation of step 5 is: performing flow cytometry surface characteristic antigen analysis on the neural stem cells obtained by in vitro culture.
[0023] Compared with the prior art, the present invention has the following beneficial effects:
[0024] This method for isolating human cortical neural stem cells successfully extracted human cortical neural stem cells from abortion tissue, providing a new option for clinical application. This method uses specific antibodies to capture neural stem cells, improves separation efficiency and cell purity, and ensures the effectiveness of subsequent research and applications. It provides important research tools and methods for the field of neuroscience, which can be used for disease mechanism research and new therapy development, and has high educational and training value. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] Figure 1 This is a growth picture of human adult cerebral cortical neural stem cells in the present invention.
[0026] Figure 2 This is a graph showing the flow cytometry results of neural stem cells in the present invention. DETAILED DESCRIPTION
[0027] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.
[0028] The specific implementation of the present invention is described in detail below in conjunction with specific embodiments.
[0029] An embodiment of the present invention provides a method for isolating human cerebral cortex neural stem cells, comprising the following steps:
[0030] Step 1: Collection of abortion tissue;
[0031] The specific operation of step 1 is as follows: for gestational age of 5 to 16 weeks, the selective abortion tissue is defined as pathological medical waste according to the regulations "Medical Waste Classification Catalog (2021 Edition)", and the donor screening standards are formulated in accordance with the requirements of the current Good Tissue Practice (cGTP) for human cell tissues. The tissue collection research plan does not make any changes to the clinical selective abortion operation specifications. For drug-induced intact abortion tissue, after washing it with HBSS (Hyclone) several times, the meninges are peeled off with tweezers, and the cerebral cortex is separated in the abortion tissue by microdissection, and different tissues are cut into pieces less than 1 mm. 3 The tissue blocks were placed in PBS pre-cooled at 4°C for later use.
[0032] Step 2, preparation of single cell suspension of neural tissue;
[0033] The specific operation of step 2 is as follows: centrifuge the tissue block at a centrifugal force of 150g for 3 minutes, and then discard the supernatant; place the centrifuged tissue block on ice for 15 minutes, and flick the tissue block every 2 minutes until the tissue block is completely resuspended; use a pipette to blow the tissue block up and down every 30 seconds until the tissue block becomes a uniform single-cell suspension (no obvious tissue clumps appear in the liquid), and then centrifuge the obtained single-cell suspension at a centrifugal force of 300g for 10 minutes; then use complete culture medium to resuspend the cell pellet, perform cell counting, and let it stand for subsequent culture experiments.
[0034] Step 3, neural stem cell immune capture;
[0035] The specific operation of step 3 is: using CD133 antibody (provided by abcam, product number ab252553) and CD29 antibody (provided by abcam, product number ab24693) to achieve specific capture and activation of neural stem cells. The specific steps of step 3 are as follows:
[0036] Step 31, preparation of coated plates: use 0.01% poly-L-ornithine (Sigma, P0899) and 0.01% fibronectin (Sigma, F1056) to coat the plates overnight; wash the plates with DPBS, and then use 2ug / ml neural stem cell specific antibodies CD133 and CD29 antibodies (abcam, ab252553 and ab24693) to coat the plates, incubate at 37°C for 1 hour or at 4°C overnight, and then store the plates at 4°C for future use. The prepared plates should be used within 3 days;
[0037] Step 32, adding cell suspension and incubation: Before use, remove the liquid in the plate and add 1×10 7cells / mL neural tissue single cell suspension was added to the coated dish, mixed thoroughly, and the dish was placed in an incubator for 4 to 8 hours;
[0038] Step 33, washing the non-adherent cells: after the incubation is completed, tilt the plate and pour out all the liquid at the bottom of the plate;
[0039] Step 34, adding complete culture medium: slowly add 1-2 ml of complete culture medium along the wall of the dish, and repeat step 33 once;
[0040] Step 35, add a sufficient amount of neural stem complete culture medium to the plate, and then place the plate in a 37° C., 5% incubator for culture.
[0041] Step 4: Cultivating neural stem cells;
[0042] The specific operation of step 4 is: after culturing neural stem cells for 24 hours, replace the complete medium, and then replace half of the complete medium with fresh medium every 2 days, and pay attention to observe whether there are cells growing. During the culture period, pay attention to observe the growth of cells. When the cell confluence reaches 50-60%, digestion and 1:3 subculture operation are performed, and relevant identification is performed after one generation of transfer culture. For pictures of neural stem cell growth, see Figure 1 .
[0043] Step 5: Identification of neural stem cells;
[0044] The specific operation of step 5 is: performing flow cytometry surface characteristic antigen analysis (HLA-DR+, CD34+, CD133+, CD90+, CD29+) on the neural stem cells obtained by in vitro culture, see Figure 2 The results showed that the expression rate of neural stem cell surface antigens was HLA-DR+: 5.45% (negative), CD34+: 0.21% (negative), CD133+: 99.95% (positive), CD29+: 99.94% (positive), CD90+: 99.36% (positive), which was consistent with the expression characteristics of neural stem cell surface antigens.
[0045] In summary, the identification results of the neural stem cells purified by the present invention show that the neural stem cells obtained by the separation and extraction technology have the basic characteristics of neural stem cells.
[0046] The antibodies used in the present invention are shown in Table 1:
[0047] Table 1 List of antibodies used
[0048] Antibody Name brand Part Number use HLA-DR-PC5.5 <![CDATA[BD TM ]]> 339205 Flow cytometry CD34-FITC <![CDATA[BD TM ]]> 555821 Flow cytometry CD133-APC <![CDATA[BD TM ]]> 566596 Flow cytometry CD29-PE <![CDATA[BD TM ]]> 557332 Flow cytometry CD90-PE <![CDATA[BD TM ]]> 551401 Flow cytometry
[0049] The above are only preferred embodiments of the present invention. It should be pointed out that, for those skilled in the art, several modifications and improvements can be made without departing from the concept of the present invention. These should also be regarded as the protection scope of the present invention. These will not affect the effect of the implementation of the present invention and the practicality of the patent.
Claims
1. A method for isolating human cerebral cortex neural stem cells, characterized in that: The following steps are involved: Step 1: Collection of abortion tissue; Step 2, preparation of single cell suspension of neural tissue; Step 3, neural stem cell immune capture; Step 4: Cultivating neural stem cells; Step 5: Identification of neural stem cells.
2. The method for isolating human cerebral cortex neural stem cells according to claim 1, characterized in that: The specific operation of step 1 is as follows: for the intact abortion tissue induced by drugs, after washing it with HBSS for several times, the meninges are peeled off with forceps, and the parts of the cerebral cortex in the abortion tissue are separated by microdissection, and different tissues are cut into pieces less than 1 mm 3 The tissue blocks were placed in PBS pre-cooled at 4°C for later use.
3. The method for isolating human cerebral cortex neural stem cells according to claim 1, characterized in that: The specific operation of step 2 is: centrifuge the tissue block at a centrifugal force of 150g for 3 minutes, and then discard the supernatant; place the centrifuged tissue block on ice for 15 minutes, and flick the tissue block every 2 minutes until the tissue block is completely resuspended; use a pipette to blow the tissue block up and down every 30 seconds until the tissue block becomes a uniform single-cell suspension, and then centrifuge the obtained single-cell suspension at a centrifugal force of 300g for 10 minutes; then use complete culture medium to resuspend the cell pellet, count the cells, and let it stand for subsequent culture experiments.
4. The method for isolating human cerebral cortex neural stem cells according to claim 1, characterized in that: The specific operation of step 3 is: using CD133 antibody and CD29 antibody to achieve specific capture and activation of neural stem cells.
5. The method for isolating human cerebral cortex neural stem cells according to claim 4, characterized in that: The specific steps of step 3 are as follows: Step 31, preparation of coated plates: coat the plates with 0.01% poly-L-ornithine and 0.01% fibronectin in sequence overnight; wash the plates with DPBS, and then coat the plates with 2ug / ml neural stem cell-specific antibodies CD133 and CD29 antibodies, incubate at 37°C for 1 hour or at 4°C overnight, and then store the plates at 4°C for later use. The prepared plates should be used within 3 days; Step 32, adding cell suspension and incubation: Before use, remove the liquid in the plate and add 1×10 7 cells / mL neural tissue single cell suspension was added to the coated dish, mixed thoroughly, and the dish was placed in an incubator for 4 to 8 hours; Step 33, washing the non-adherent cells: after the incubation is completed, tilt the plate and pour out all the liquid at the bottom of the plate; Step 34, adding complete culture medium: slowly add 1-2 ml of complete culture medium along the wall of the dish, and repeat step 33 once; Step 35, add a sufficient amount of neural stem complete culture medium to the plate, and then place the plate in a 37° C., 5% incubator for culture.
6. The method for isolating human cerebral cortex neural stem cells according to claim 1, characterized in that: The specific operation of step 4 is as follows: after culturing neural stem cells for 24 hours, the complete medium is replaced, and then half the amount of fresh complete medium is replaced every 2 days. When the cell confluence reaches 50-60%, digestion and 1:3 subculture operation are performed, and relevant identification is performed after one generation of transfer culture.
7. The method for isolating human cerebral cortex neural stem cells according to claim 1, characterized in that: The specific operation of step 5 is: performing flow cytometry surface characteristic antigen analysis on the neural stem cells obtained by in vitro culture.
Citation Information
Patent Citations
Method for culturing human neural stem cells
CN114369574A
Method of isolating and culturing for neural stem cell
KR101994640B1
Neural stem cell injection for treating brain damage diseases and preparation method and use method thereof
WO2018103406A1
